Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
Saved in:
| Date: | 2016 |
|---|---|
| Main Authors: | Yu. O. Tymovska, O. S. Zotov, V. M. Pivniuk, M. F. Anikusko |
| Format: | Article |
| Language: | English |
| Published: |
2016
|
| Series: | Oncology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000490853 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Surgery features in the treatment of patients with HER2-neu positive breast cancer
by: I. Y. Halaichuk
Published: (2020)
by: I. Y. Halaichuk
Published: (2020)
Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
by: B. T. Klimuk, et al.
Published: (2017)
by: B. T. Klimuk, et al.
Published: (2017)
Impact of ASCO/CAP 2007, 2013 and 2018 recommendations on Her-2/neu gene amplification status testing in patients with breast cancer
by: B. T. Klimuk, et al.
Published: (2019)
by: B. T. Klimuk, et al.
Published: (2019)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: J. Zekri, et al.
Published: (2015)
by: J. Zekri, et al.
Published: (2015)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)
by: Zekri, J., et al.
Published: (2015)
Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer
by: Shapochka, D.O., et al.
Published: (2012)
by: Shapochka, D.O., et al.
Published: (2012)
Superroxide radicals: initiation of metastases in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2017)
by: A. P. Burlaka, et al.
Published: (2017)
Modern algorithm of treatment of patients with breast cancer and metastases in bone
by: O. V. Ponomareva, et al.
Published: (2015)
by: O. V. Ponomareva, et al.
Published: (2015)
Експресія Her2/neu при недрібноклітинному раку легені та її прогностичне значення
by: Суховерша, О.А., et al.
Published: (2007)
by: Суховерша, О.А., et al.
Published: (2007)
Особливості експресії білків HER-2/neu та VEGF у граничних пухлинах яєчника
by: Клименко, Е.С., et al.
Published: (2014)
by: Клименко, Е.С., et al.
Published: (2014)
Оценка мутационного статуса гена Her2/neu в клетках рака молочной железы
by: Клименко, С.В., et al.
Published: (2007)
by: Клименко, С.В., et al.
Published: (2007)
HER2/neu як мішень терапії у хворих на недрібноклітинний рак легені
by: Суховерша, О.А., et al.
Published: (2007)
by: Суховерша, О.А., et al.
Published: (2007)
Пероральна хіміоендокринотерапія хворих на метастазуючий люмінальний Her-2/neu негативний рак молочної залози
by: Тимовська, Ю.О., et al.
Published: (2016)
by: Тимовська, Ю.О., et al.
Published: (2016)
Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)
by: Chekhun, V.F., et al.
Published: (2023)
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Клиническое значение рецепторов эстрогенов, прогестерона и онкобелка her-2/neu в клетках рака молочной железы
by: Петрухин, В.И., et al.
Published: (2002)
by: Петрухин, В.И., et al.
Published: (2002)
Evolution of views on the palliative treatment of metastasing forms of colorectal cancer in the era of target therapy
by: O. V. Ponomareva
Published: (2017)
by: O. V. Ponomareva
Published: (2017)
Mesoporous silica materials as sensitive components for chemo- and biosensors
by: Telbiz, G.M., et al.
Published: (2005)
by: Telbiz, G.M., et al.
Published: (2005)
Balance model for contactless chemo-mechanical polishing of wafers
by: Grigoriev, N.N., et al.
Published: (2002)
by: Grigoriev, N.N., et al.
Published: (2002)
Prophylaxis of hepatic complications at antihelicobacter therapy with oral antidysbiotic gel
by: I. N. Shukhtina
Published: (2015)
by: I. N. Shukhtina
Published: (2015)
Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas
by: Buchynska, L.G., et al.
Published: (2023)
by: Buchynska, L.G., et al.
Published: (2023)
Immune checkpoint blockade in breast cancer therapy
by: I. A. Gromakova, et al.
Published: (2020)
by: I. A. Gromakova, et al.
Published: (2020)
Stem cell therapy for hereditary breast cancer
by: Rassi, H.
Published: (2009)
by: Rassi, H.
Published: (2009)
Клиническое значение экспрессии HER-2/neu у больных серозным раком яичника в зависимости от статуса гормональных рецепторнов опухоли
by: Ткаля, Ю.Г., et al.
Published: (2014)
by: Ткаля, Ю.Г., et al.
Published: (2014)
Експресія молекулярних маркерів (NF-kB, ER, PR, Her2/neu) в пухлинах хворих на рак молочної залози
by: Шапочка, Д.О., et al.
Published: (2012)
by: Шапочка, Д.О., et al.
Published: (2012)
Syndromes of multiple endocrine neoplasias
by: B. Bilynskyi, et al.
Published: (2015)
by: B. Bilynskyi, et al.
Published: (2015)
Postmastectomy radiation therapy in locally advanced breast cancer
by: G. Yavas, et al.
Published: (2013)
by: G. Yavas, et al.
Published: (2013)
Postmastectomy radiation therapy in locally advanced breast cancer
by: Yavas, G., et al.
Published: (2013)
by: Yavas, G., et al.
Published: (2013)
Thyroid metastases from a breast cancer diagnosed by fine-needle aspiration biopsy. Case report and overview of the literature
by: Lacka, K., et al.
Published: (2012)
by: Lacka, K., et al.
Published: (2012)
Comparative analysis of the efficacy of definitive chemoradiation therapy and surgery followed by adjuvant radiation therapy in advanced-stage oral tongue cancer
by: Kravets, O.V., et al.
Published: (2023)
by: Kravets, O.V., et al.
Published: (2023)
Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)
by: Ju. Ju. Belevtsova
Published: (2019)
The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
by: Liubota, R., et al.
Published: (2017)
by: Liubota, R., et al.
Published: (2017)
Ефективність різних схем гормонотерапії хворих на рак молочної залози залежно від менструального статусу, експресії рецепторів стероїдних гормонів та Her2/neu
by: Жильчук, В.Є.
Published: (2010)
by: Жильчук, В.Є.
Published: (2010)
Using the combined chemo-immunotherapy based on dendritic cells and low-dose doxorubicin in experiment
by: O. I. Horbach, et al.
Published: (2013)
by: O. I. Horbach, et al.
Published: (2013)
First treatment activity and outcome of radioiodine therapy in thyroid cancer patients with metastases in lymph nodes: mathematical correlation and clinical implica
by: Kozak, O.V., et al.
Published: (2006)
by: Kozak, O.V., et al.
Published: (2006)
Endocrine status of patients with osteoarthritis and metabolic syndrome
by: L. N. Yefremenkova
Published: (2015)
by: L. N. Yefremenkova
Published: (2015)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
Role of hormone therapy in treatment of early breast cancer in premenopausal women
by: M. V. Sadchikova, et al.
Published: (2019)
by: M. V. Sadchikova, et al.
Published: (2019)
Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
by: Chekhun, V.F., et al.
Published: (2009)
by: Chekhun, V.F., et al.
Published: (2009)
Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
by: B. Yalcin
Published: (2013)
by: B. Yalcin
Published: (2013)
Similar Items
-
Surgery features in the treatment of patients with HER2-neu positive breast cancer
by: I. Y. Halaichuk
Published: (2020) -
Results of mutation status gene HER-2/NEU in patients with breast cancer in Ukraine
by: B. T. Klimuk, et al.
Published: (2017) -
Impact of ASCO/CAP 2007, 2013 and 2018 recommendations on Her-2/neu gene amplification status testing in patients with breast cancer
by: B. T. Klimuk, et al.
Published: (2019) -
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: J. Zekri, et al.
Published: (2015) -
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)